NSE: HCG | BSE: 539787

Await Turnaround

Download real time

549.55 9.10 (1.68%)

59.31% Gain from 52W Low

122.7K NSE+BSE Volume

NSE 26 Jun, 2025 12:30 PM (IST)

7,661.6

Market Cap

Above industry Median

0.6

Beta 1Year

Very Low volatility

Healthcare Global Enterprises Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for HCG, BSE:539787 Healthcare Global Enterprises Ltd.

Search Inside the pdf :

Healthcare Global Enterprises Ltd.

27 May 2025

549.55

1.68%

Result Update:Health.Global

Buy: Healthcare Global Enterpri...

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Healthcare Global Enterprises Ltd. has gained 45.92% in the last 1 Year

Healthcare Global Enterprises Ltd.

27 May 2025

549.55

1.68%

HealthCare Global Enterprises (HCG IN) Q4FY25 Result Update ...

Buy: Healthcare Global Enterpri...

Target

Prabhudas Lilladhar

HealthCare Global Enterprises' (HCG) Q4 consolidated EBITDA grew by 15% YoY to Rs1.1bn; in line with our estimate. The company's asset-light approach with a focus on partnerships has made its business model more capital efficient and scalable, in our view. We believe the strategic investment by KKR will bring in more operational and financial efficiency. Currently, HCG enjoys 13-14% pre IND AS margin, which is lower than its peers. We expect KKR to drive growth through bed expansion, rationalization of existing assets and scale up of...

Healthcare Global Enterprises Ltd. is trading below its 30 day SMA of 558.0

Healthcare Global Enterprises Ltd.

21 Apr 2025

549.55

1.68%

HEALTHCARE GLOBAL ENTERPRISES LIMITED

Hold: Healthcare Global Enterpri...

Target

Geojit BNP Paribas

Healthcare Global En.. has an average target of 598.60 from 5 brokers.

Healthcare Global Enterprises Ltd.

28 Feb 2025

549.55

1.68%

Result Update:Health.Global

Buy: Healthcare Global Enterpri...

Axis Direct

We maintain our BUY recommendation on the stock.

Healthcare Global Enterprises Ltd. is trading below its 30 day SMA of 558.0

Healthcare Global Enterprises Ltd.

28 Feb 2025

549.55

1.68%

HealthCare Global Enterprises (HCG IN) Event Update Ownership...

Buy: Healthcare Global Enterpri...

Target

Prabhudas Lilladhar

With 51% stake in HCG, KKR has become the largest shareholder. We believe the strategic investment by KKR will bring in more operational and financial efficiency. Currently, HCG enjoys 15% pre IND AS margin, which is lower than its peers. We expect KKR to drive growth through bed expansion, rationalization of existing assets and scale up of margins. The company's asset-light approach with a focus on partnerships has made its business model more capital efficient and scalable, in our view. Our FY26/FY27E EBITDA stands...

Healthcare Global En.. has an average target of 598.60 from 5 brokers.

Healthcare Global Enterprises Ltd.

25 Feb 2025, 12:00AM

549.55

1.68%

PE change of hands to improve prospects

Hold: Healthcare Global Enterpri...

Target

ICICI Securities Limited

HealthCare Global Enterprises’ (HCG) current promoter CVC Capital (Aseco PTE) is likely to sell up to 54% of its stake in the company to another private equity (PE) firm, KKR, at an agreed price of INR 445/share (cumulative value between INR 320bn–339bn).